Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-23-001650

Chief Executive Officer sold 5,675 shares at $224.36 ($1,273,269)

  • Chief Executive Officer acquired 5,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Farrell Michael J. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-17 Exercise or conversion : show line 1 in the form +5,675 $57.76 $327,788 442,575 D
2023-01-17 Sale : show line 2 in the form −5,675 $224.36 $1,273,269 436,900 D
Open-market sales · 5,675 sh · avg $224.36 · $1,273,269

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-17 Exercise or conversion : show line 3 in the form ResMed Common Stock Options −5,675 60,215 D
Loading xslF345X03/form4.xml…